Adjuvant Capital

๐Ÿ“ New York City, US
๐Ÿท๏ธ vc
Visit Website โ†—
Investment Thesis

Adjuvant Capital invests in life sciences technologies addressing critical global public health challenges, particularly in emerging economies. By focusing on underserved markets and leveraging expertise to accelerate impactful innovations, the firm aims to generate both financial and social returns. The firm targets innovations in infectious diseases (HIV/AIDS, tuberculosis, malaria, tropical diseases, pandemics), maternal/child health, nutrition, and reproductive/sexual health, with a preference for technologies that have already proven safety and efficacy in humans.

Stage Focus
Preferred equity in technologies demonstrating safety and efficacy in humans (post-human trials)

Preferred startup development maturity for initial funding deployment.

Sectors & Themes

High-burden public health challenges, neglected infectious diseases, maternal and child health, nutrition, reproductive and sexual health, antimicrobial resistance, pandemic threats

Core thematic spaces, technologies, and target market segments of interest.

Check Size Range
N/A

Standard financial allocation per investment round.

Outreach & Dossier Intelligence

Direct Verification Contact Email Pattern

[email protected] | [email protected]

Thesis Dossier Analysis Scorecard

Our agent analyzer scanned portfolio holdings and verified absolute match parameters...

Unlock Verified Partner Contacts

Find verified email templates, direct outreach copy created by AI, and calculate exact thesis match scores with 1-click.

Create Free Account to Unlock

Takes less than 30 seconds ยท No card required

Investment Team (19)